Sensus Healthcare Inc Down 4.28% To $2.13 After Earnings Miss

Sensus Healthcare Inc (SRTS) said after close Thursday that it lost $0.09 per share in quarter three 2023.

On the revenue line, the company reported $3.9 million, missing estimates by $2 million.

In the same quarter a year ago, the company earned $0.11 per share on revenue of $9 million.

The stock is down 4.28% to $2.13 after the report.

Sensus Healthcare Inc's profit margins took a hit as earnings fell at a faster pace than revenues.

The average recommendation from Wall Street analysts was a Strong Buy which may get revised based on this new data.

Trading in the five days leading up to the report earned Sensus Healthcare Inc a Bullish Sentiment Rank from InvestorsObserver.

Sensus Healthcare Inc has performed poorly during the past few months, garnering a low Long-Term Technical Rank by InvestorsObserver of 20, putting Sensus Healthcare Inc in the bottom 25% of stocks. The firm was recently trading at a 52-week low of $2.05 on November 1, 2023 and set a 52-week high on January 18, 2023 at $9.62.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated primarily from customers in the United States.